• Mashup Score: 1

    FDA Oncology Center of Excellence (OCE) launched Project Orbis in May 2019 with international regulatory authorities as a global collaborative review program for oncology marketing applications. Current Project Orbis partners include the regulatory health authorities of Australia, Brazil, Canada, Singapore, Switzerland, and the United Kingdom.

    Tweet Tweets with this article
    • Join us for FDA Grand Rounds on May 13 to hear #FDAOncology's Dr. Angelo de Claro talk about #OCEProjectOrbis, a global collaborative review program in oncology. Register now: https://t.co/HwBLsIVT6X https://t.co/CvBhZmHVT0